Rankings
▼
Calendar
SUPN Q1 2016 Earnings — Supernus Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
SUPN
Supernus Pharmaceuticals, Inc.
$3B
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$43M
Gross Profit
$41M
95.3% margin
Operating Income
$5M
12.3% margin
Net Income
$5M
11.2% margin
EPS (Diluted)
$0.08
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$194M
Total Liabilities
$66M
Stockholders' Equity
$128M
Cash & Equivalents
$45M
← FY 2016
All Quarters
Q2 2016 →
